Caladrius Biosciences, (CLBS). Shares dropped -7.59% to $1.34 in the after-market session after it was reported that the agenda for the quarterly Life Sciences Investor Forum is available for public and private companies across the world, as well as investors and industry professionals. Throughout the day, a live company presentation and interactive discussion will be held regarding the life sciences industry.
Investors, advisors and analysts are encouraged to attend. The event begins at 9:30 AM ET Thursday, December 17th.
